We hypothesized that TFR patients have a higher number of CML‐specific T‐cell clones in order to eradicate leukemic cells; therefore, we conducted TCR repertoire analysis of patients who attempted TKI discontinuation. This evidence concerns the gene TFRC and chronic myelogenous leukemia, BCR-ABL1 positive.